ICD-10 Coding for Adenocarcinoma of Esophagus(C15.0, C15.0M, C15.0N)
Learn about ICD-10 coding for adenocarcinoma of the esophagus, including specific codes for different esophageal locations and documentation requirements.
Complete code families applicable to Adenocarcinoma of Esophagus
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C15.0 | Malignant neoplasm of cervical esophagus | Use when the tumor is located in the cervical esophagus. |
|
| C15.1 | Malignant neoplasm of thoracic esophagus | Use when the tumor is located in the thoracic esophagus. |
|
| C15.2 | Malignant neoplasm of abdominal esophagus | Use when the tumor is located in the abdominal esophagus. |
|
| C15.3 | Malignant neoplasm of upper third of esophagus | Use when the tumor is located in the upper third of the esophagus. |
|
| C15.4 | Malignant neoplasm of middle third of esophagus | Use when the tumor is located in the middle third of the esophagus. |
|
| C15.5 | Malignant neoplasm of lower third of esophagus | Use when the tumor is located in the lower third of the esophagus. |
|
| C15.8 | Malignant neoplasm of overlapping sites of esophagus | Use when the tumor spans multiple regions of the esophagus. |
|
| C15.9 | Malignant neoplasm of esophagus, unspecified | Use when the specific location of the tumor is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAdenocarcinoma of Esophagus
Documentation & Coding Risks
Avoid these common issues when documenting Adenocarcinoma of Esophagus.
Using unspecified codes when specific location is known
Impact
Clinical: Leads to less precise treatment planning, Regulatory: Increases audit risk, Financial: May result in lower reimbursement
Mitigation
Ensure documentation includes specific tumor location, Cross-check pathology and imaging reports
Coding C15.9 when specific location is documented
Impact
Reimbursement: May lead to lower reimbursement rates, Compliance: Increases audit risk, Data Quality: Reduces specificity of healthcare data
Mitigation
Ensure documentation specifies tumor location to use specific codes
Use of unspecified codes
Impact
High audit risk when using unspecified codes without justification.
Mitigation
Ensure documentation specifies tumor location and histology.